Jim Simons Bausch Health Companies Inc. Transaction History

Renaissance Technologies LLC

$63.4 Billion
Q4 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 495,172 shares of BHC stock, worth $3.41 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

495,172

Previous 26,600 1761.55%

Holding current value

$3.41 Million

Previous $216,000 1747.69%

% of portfolio

0.01%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$7.34 - $9.78 $3.44 Million - $4.58 Million	468,572 Added 1761.55%	495,172 $3.99 Million
Q3 2024 Nov 13, 2024	BUY	$5.22 - $8.26 $138,852 - $219,716	26,600 New	26,600 $216,000
Q1 2024 May 13, 2024	SELL	$7.77 - $10.61 $1.94 Million - $2.65 Million	-249,689 Reduced 94.12%	15,600 $165,000
Q4 2023 Feb 13, 2024	BUY	$6.53 - $8.23 $1.73 Million - $2.18 Million	265,289 New	265,289 $2.13 Million
Q1 2023 May 12, 2023	BUY	$6.28 - $9.85 $7.13 Million - $11.2 Million	1,135,289 New	1,135,289 $9.2 Million
Q2 2022 Aug 12, 2022	SELL	$7.06 - $23.63 $4.3 Million - $14.4 Million	-609,746 Reduced 52.85%	544,043 $4.55 Million
Q1 2022 May 13, 2022	BUY	$21.6 - $27.79 $22.4 Million - $28.9 Million	1,038,789 Added 903.29%	1,153,789 $26.4 Million
Q4 2021 Feb 11, 2022	BUY	$23.0 - $29.01 $2.11 Million - $2.66 Million	91,700 Added 393.56%	115,000 $3.18 Million
Q3 2021 Nov 12, 2021	SELL	$25.04 - $30.06 $17.5 Million - $21 Million	-698,089 Reduced 96.77%	23,300 $650,000
Q2 2021 Aug 13, 2021	SELL	$27.43 - $32.7 $218,644 - $260,651	-7,971 Reduced 1.09%	721,389 $21.2 Million
Q1 2021 May 13, 2021	SELL	$21.37 - $34.38 $26.9 Million - $43.3 Million	-1,260,800 Reduced 63.35%	729,360 $23.2 Million
Q4 2020 Feb 10, 2021	SELL	$15.31 - $21.12 $25.4 Million - $35 Million	-1,656,500 Reduced 45.43%	1,990,160 $41.4 Million
Q3 2020 Nov 13, 2020	SELL	$14.88 - $20.13 $69 Million - $93.3 Million	-4,634,589 Reduced 55.96%	3,646,660 $56.7 Million
Q2 2020 Aug 13, 2020	SELL	$13.31 - $20.51 $68.2 Million - $105 Million	-5,121,100 Reduced 38.21%	8,281,249 $151 Million
Q1 2020 May 14, 2020	BUY	$12.98 - $30.25 $11.8 Million - $27.5 Million	910,550 Added 7.29%	13,402,349 $208 Million
Q4 2019 Feb 13, 2020	BUY	$18.89 - $31.89 $140 Million - $237 Million	7,429,396 Added 146.76%	12,491,799 $374 Million
Q3 2019 Nov 13, 2019	BUY	$20.88 - $25.66 $42.3 Million - $52 Million	2,025,203 Added 66.68%	5,062,403 $111 Million
Q2 2019 Aug 12, 2019	BUY	$20.52 - $26.45 $5.58 Million - $7.19 Million	272,000 Added 9.84%	3,037,200 $76.6 Million
Q1 2019 May 14, 2019	BUY	$20.23 - $26.29 $12.8 Million - $16.6 Million	631,500 Added 29.6%	2,765,200 $68.3 Million
Q4 2018 Feb 13, 2019	BUY	$17.64 - $28.32 $37.6 Million - $60.4 Million	2,133,700 New	2,133,700 $39.4 Million

Others Institutions Holding BHC

# of Institutions

271

Shares Held

252M

Call Options Held

5.12M

Put Options Held

9.43M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.49B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account